These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 327456)

  • 1. The development of mexiletine.
    Köppe HG
    Postgrad Med J; 1977; 53 Suppl 1():22-4. PubMed ID: 327456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis of mexiletine analogs].
    Xia L; Ni PZ; Ji M
    Yao Xue Xue Bao; 1984 Sep; 19(9):656-9. PubMed ID: 6536176
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of mexiletine.
    Danneberg PB; Shelley JH
    Postgrad Med J; 1977; 53 Suppl 1():25-9. PubMed ID: 876950
    [No Abstract]   [Full Text] [Related]  

  • 4. Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator.
    Frederickson M; Callaghan O; Chessari G; Congreve M; Cowan SR; Matthews JE; McMenamin R; Smith DM; Vinković M; Wallis NG
    J Med Chem; 2008 Jan; 51(2):183-6. PubMed ID: 18163548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.
    Middleton D
    Acta Cardiol Suppl; 1980; (25):45-53. PubMed ID: 6990666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific synthesis of "para-hydroxymexiletine" and sodium channel blocking activity evaluation.
    Catalano A; Carocci A; Fracchiolla G; Franchini C; Lentini G; Tortorella V; De Luca A; De Bellis M; Desaphy JF; Conte Camerino D
    Chirality; 2004 Feb; 16(2):72-8. PubMed ID: 14712469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels.
    Franchini C; Carocci A; Catalano A; Cavalluzzi MM; Corbo F; Lentini G; Scilimati A; Tortorella P; Camerino DC; De Luca A
    J Med Chem; 2003 Nov; 46(24):5238-48. PubMed ID: 14613326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mexitil (Mexiletine). A new antiarrhythmic agent].
    Bjerregaard P
    Ugeskr Laeger; 1980 Oct; 142(43):2855-6. PubMed ID: 7445202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of mexiletine and lidocaine in coronary surgery patients].
    Fritz KW; Lüllwitz E; Scheld H; Kirchner E
    Anasth Intensivther Notfallmed; 1983 Jun; 18(3):125-8. PubMed ID: 6614412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman DC; Dunning AJ
    Postgrad Med J; 1977; 53 Suppl 1():92-6. PubMed ID: 876958
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations of the haemodynamics of mexiletine.
    Banim SO; Da Silva A; Stone D; Balcon R
    Postgrad Med J; 1977; 53 Suppl 1():74-7. PubMed ID: 876956
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic effects of parenteral and oral mexiletine.
    Renard M; de Hemptinne J; Gillet JM; Bernard R
    Acta Cardiol Suppl; 1980; (25):75-80. PubMed ID: 6966455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Clinical electrophysiological effects of mexiletine and its mechanism of antidysrhythmic action.
    McComish M; Crook B; Kitson D; Jewitt D
    Br Heart J; 1976 Mar; 38(3):311. PubMed ID: 1259850
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of an intravenous injection of mexiletine in patients hospitalised in intensive care units.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):101-7. PubMed ID: 6966451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mexiletine on left ventricular ejection: a comparison with lignocaine and propranolol.
    Shaw TR
    Postgrad Med J; 1977; 53 Suppl 1():69-73. PubMed ID: 876955
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrophysiologic actions of mexiletine (Kö-1173) in man].
    González Maqueda I; García Fernández F; Martín Jadraque L
    Med Clin (Barc); 1981 Mar; 76(5):223-5. PubMed ID: 7206892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects of a new anti-arrhythmia agent: mexiletine].
    Tomassetti V; Fontana F; Masi M; Mezzetti A; Poggiopollini G; Cuppini A; Cuccurullo F
    Boll Soc Ital Cardiol; 1980; 25(1):95-100. PubMed ID: 7236434
    [No Abstract]   [Full Text] [Related]  

  • 18. [The anti-arrhythmic action of mexiletine: experimental study].
    Ciraolo O; Quartarone M; Corica F; D'Andrea Petrelli L; Barbera N; Ceruso D
    G Clin Med; 1983 Nov; 64(11):483-90. PubMed ID: 6667804
    [No Abstract]   [Full Text] [Related]  

  • 19. Substrate selective inhibition of monoamine oxidase by mexiletine [proceedings].
    Callingham BA
    Br J Pharmacol; 1977 Sep; 61(1):118P-119P. PubMed ID: 912170
    [No Abstract]   [Full Text] [Related]  

  • 20. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.